Paclitaxel‐Coated Balloon for Treating In‐Stent Restenosis in Racial and Ethnic Minority Patients: A Subanalysis From the AGENT IDE Trial

In this prespecified analysis of the AGENT IDE trial, 1-year outcomes following DCB angioplasty were comparable between minority and non-Hispanic White patients. Although wide CIs limited the exclusion of clinically meaningful differences in outcomes between these groups, the relative efficacy of DCB versus balloon angioplasty was consistent across race and ethnicity. Registration: ClinicalTrials.gov; Identifier: NCT04647253. URL: https://www.clinicaltrials.gov/study/NCT04647253.

Authors

Institutions

Publication Details

Journal
Journal of the American Heart Association
Published
2026-01-19
DOI
https://doi.org/10.1161/jaha.125.043053
Primary Topic
Coronary Interventions and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Paclitaxel‐Coated Balloon for Treating In‐Stent Restenosis in Racial and Ethnic Minority Patients: A Subanalysis From the AGENT IDE Trial

Steven Gregg Rudick, Behnam Nonahal Tehrani, John D. Altman, Rafael Noronha Cavalcante et al.
Journal of the American Heart Association
Coronary Interventions and Diagnostics
article

Paclitaxel‐Coated Balloon for Treating In‐Stent Restenosis in Racial and Ethnic Minority Patients: A Subanalysis From the AGENT IDE Trial

Steven Gregg Rudick, Behnam Nonahal Tehrani, John D. Altman, Rafael Noronha Cavalcante, Carey Kimmelstiel, Yasser Jamil, Robert C. Stoler, Brian Jefferson, Richard Shlofmitz, Amar Krishnaswamy, William Nicholson, Suhail Dohad, Ajay Kirtane, Arthur Reitman, Jeffrey Moses, Wayne B. Batchelor, Robert W. Yeh, William Bachinsky
article en

Abstract

In this prespecified analysis of the AGENT IDE trial, 1-year outcomes following DCB angioplasty were comparable between minority and non-Hispanic White patients. Although wide CIs limited the exclusion of clinically meaningful differences in outcomes between these groups, the relative efficacy of DCB versus balloon angioplasty was consistent across race and ethnicity. Registration: ClinicalTrials.gov; Identifier: NCT04647253. URL: https://www.clinicaltrials.gov/study/NCT04647253.

Journal of the American Heart AssociationVol. 15(2)
Inova Health System (US), Cedars-Sinai Medical Center (US), Tufts Medical Center (US), Beth Israel Deaconess Medical Center (US), Cleveland Clinic (US), Columbia University Irving Medical Center (US), Emory University Hospital (US), WellStar Kennestone Hospital (US), Henry Ford Hospital (US), Centennial Medical Center (US), St Francis’ Hospital (ZM), Boston Scientific (Netherlands) (NL), Heart Hospital Baylor Plano (US), St Francis Chronic Hospital (ZA), Christ Hospital (US), University of Pittsburgh Medical Center (US), Baylor Jack and Jane Hamilton Heart and Vascular Hospital (US), St. Francis Referral Hospital (TZ), Naggalama Hospital (UG), Christ Hospital (US), Baylor Scott & White Health (US)
Openalex Percentile: Top 84%
Coronary Interventions and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.